실험실 자동화 시장 : 유형별, 제공 형태별, 전개 모드별, 용도, 최종 사용자별 - 시장 예측(2026-2032년)

The Laboratory Automation Market was valued at USD 6.79 billion in 2024 and is projected to grow to USD 7.30 billion in 2025, with a CAGR of 7.84%, reaching USD 12.43 billion by 2032.

An authoritative introduction outlining the strategic context and operational priorities reshaping laboratory automation adoption and procurement strategies

The laboratory automation landscape is undergoing a profound transition as laboratories across the life sciences, clinical diagnostics, environmental testing, and food safety sectors pursue higher throughput, reproducibility, and operational resilience. This introduction frames the context for a strategic executive summary that synthesizes technological evolution, changing procurement models, and shifting end-user expectations. Laboratories are no longer optimizing single instruments in isolation; they are integrating hardware, software, services, and workflows to achieve scalable, auditable results that support faster decision cycles.

Across many institutions, the convergence of modular system architectures and fully integrated automation platforms is redefining how experiments are designed and executed. This shift is accompanied by a more sophisticated buyer profile that demands configurable solutions, measurable service-level commitments, and data infrastructures that can interoperate across instruments. As a result, procurement and engineering teams are placing equal emphasis on instrument performance, software maturity, and the availability of consulting and training services that enable rapid adoption.

The remainder of this executive summary will unpack these themes, exploring the technological inflection points, regulatory and trade considerations, segmentation-driven priorities, regional nuances, and practical recommendations that decision-makers can use to align strategy with operational realities. The aim is to provide a compact, actionable narrative that supports board-level discussions and helps operational leaders prioritize near-term investments while building long-term capabilities.

Deep examination of the technological and commercial inflection points driving modularity, integrated platforms, and service-led automation adoption across laboratories

The laboratory automation landscape has entered a period of transformative shifts driven by modularity, software intelligence, and the maturation of service-led commercial models. Laboratories are increasingly choosing modular automation solutions that allow incremental capacity expansion and rapid reconfiguration to support varied workflows. This modular preference is matched by continued interest in total automation solutions where end-to-end integration and single-vendor responsibility simplify validation and long-term support. Together these models coexist and compete, pushing vendors to develop interoperable standards and open APIs to reduce lock-in while preserving differentiation.

Simultaneously, offerings have diversified beyond standalone laboratory instruments. Instrument portfolios now encompass automated liquid handling systems, automated microplate readers, automated sampling systems, automated storage and retrieval systems, and robotic arms, with robotics spanning Cartesian and SCARA architectures. Vendors are pairing these instruments with comprehensive service bundles-spanning consulting, installation and maintenance, and training and support services-and with software platforms that include chromatography data systems, electronic lab notebooks, laboratory information management systems, and scientific data management systems. The interplay between instruments, services, and software is creating new value propositions centered on outcome-based performance and minimized time-to-insight.

Applications such as clinical diagnostics, drug discovery, genomics, microbiology, and proteomics are driving adjacent requirements for throughput, data integrity, and traceability. End users across academic and research institutes, biotechnology and pharmaceutical companies, environmental testing laboratories, food and beverage organizations, and hospitals and diagnostic laboratories increasingly demand tailored solutions that align with regulatory expectations and operational constraints. This convergence of modularity, integrated offerings, and application-driven demand is catalyzing both incremental innovation and step-change investments in automation.

Comprehensive analysis of how the 2025 United States tariff adjustments have reshaped supply chains, procurement decisions, and vendor strategies in laboratory automation

Trade policy developments and tariff adjustments in the United States during 2025 have had ripple effects across laboratory automation supply chains, procurement strategies, and cost structures. Tariff-related increases in the landed cost of imported components and finished instruments have prompted procurement teams to reassess supplier footprints, sourcing strategies, and inventory policies. In many cases, the immediate reaction has been to explore alternative suppliers, increase buffer inventories for critical components, and accelerate qualification of local or regional manufacturers to reduce exposure to cross-border cost volatility.

The cumulative impact has extended beyond direct price pressure. Original equipment manufacturers and integrators are renegotiating supplier contracts, re-evaluating global assembly locations, and in some instances absorbing short-term margin compression to preserve customer relationships. For buyers, the tariff environment has sharpened focus on total cost of ownership considerations, including service frequency, consumables availability, software licensing models, and long-term maintenance commitments. These considerations are leading some organizations to favor solutions that reduce complexity-either through standardized modular components that facilitate rapid parts replacement and lower inventory diversity, or through fully integrated systems that consolidate vendor responsibility for service and spares.

At the same time, tariffs have accelerated non-tariff responses such as regionalization of manufacturing and increased collaboration between vendors and end users to localize support operations. This has implications for lead times, warranty frameworks, and the economics of spare parts provisioning. While tariffs contribute to short-term disruption and cost recalibration, they also serve as catalysts for structural supply chain changes that prioritize resilience, reduced time-to-service, and closer co-design between instrument makers and large institutional buyers.

Insightful segmentation analysis revealing differential buyer priorities across solution types, integrated offerings, application demands, and diverse end-user environments

The market segmentation provides a multi-dimensional view that reveals where innovation and commercial focus are concentrated, and how buying behaviors differ across solution types, offerings, applications, and end-user profiles. When considering solutions based on type, the distinction between modular automation solutions and total automation solutions highlights divergent buyer priorities: modular solutions attract customers valuing flexibility and incremental investment, while total solutions appeal to organizations seeking turnkey integration and a single point of accountability.

Examining the offering dimension clarifies how instrument manufacturers, service providers, and software vendors interact to deliver holistic solutions. Laboratory instruments encompass automated liquid handling systems, automated microplate readers, automated sampling systems, automated storage and retrieval systems, and robotic arms with Cartesian and SCARA variants, each addressing specific throughput, precision, and spatial constraints within workflows. Service offerings-ranging from consulting to installation and maintenance and training and support services-have become decisive differentiators as users prioritize rapid deployment, uptime guarantees, and skills transfer. Software platforms including chromatography data systems, electronic lab notebooks, laboratory information management systems, and scientific data management systems are pivotal in enabling data integrity, interoperability, and analytics-driven workflow optimization.

Application-based segmentation underlines distinct performance profiles and regulatory demands across clinical diagnostics, drug discovery, genomics, microbiology, and proteomics, shaping instrument configurations, software requirements, and service expectations. Finally, end-user segmentation across academic and research institutes, biotechnology and pharmaceutical companies, environmental testing laboratories, food and beverage companies, and hospitals and diagnostic laboratories reveals divergent procurement cycles, capital constraints, and validation requirements. Together, these segmentation lenses inform where vendors can tailor propositions, which integration challenges must be prioritized, and where consolidated go-to-market and service strategies will yield the greatest commercial traction.

Nuanced regional perspectives highlighting how disparate regulatory, procurement, and infrastructure factors shape laboratory automation adoption across major world regions

Regional dynamics exert significant influence over technology adoption pathways, regulatory compliance requirements, and vendor go-to-market strategies. In the Americas, demand is driven by high-throughput clinical diagnostics and a robust biotechnology and pharmaceutical sector that prioritize rapid deployment, validated workflows, and strong after-sales support. Procurement in this region tends to favor vendors that can guarantee compliance with local regulatory frameworks and provide responsive maintenance networks to minimize instrument downtime.

In Europe, Middle East & Africa the landscape is diverse and characterized by a mixture of well-funded research institutions, national healthcare systems with stringent procurement protocols, and emerging markets seeking cost-effective automation solutions. Vendors operating in this region must balance customization for localized regulatory and language needs with scalable support models that address widely varying facility capabilities. Interoperability and data sovereignty considerations are especially pronounced here, influencing software architectures and hosting models.

Asia-Pacific features a mix of rapidly expanding pharmaceutical R&D, growing clinical diagnostic capacity, and substantial public investment in genomics and proteomics infrastructure. This region often emphasizes rapid scaling, cost-effective modular deployments, and local manufacturing partnerships. Across all regions, the pace of digital adoption, the maturity of service ecosystems, and the prevalence of localized manufacturing capacity create differentiated opportunity profiles that vendors must navigate through tailored commercial approaches, regional partnerships, and adaptable support frameworks.

Strategic company-level insights that emphasize platform interoperability, service excellence, and validated workflow partnerships as decisive competitive differentiators

Competitive dynamics in laboratory automation are being reshaped by firms that combine deep instrumentation expertise with software capabilities and service proficiency. The most successful organizations demonstrate proficiency in systems integration, the ability to deliver validated workflows for regulated environments, and the agility to offer both modular and fully integrated solutions depending on customer needs. Strategic differentiation increasingly rests on software ecosystems that enable instrument orchestration, data traceability, and analytics-driven process improvement.

Companies that invest in robust service infrastructures-covering consulting, installation, maintenance, and comprehensive training-tend to secure longer-term customer relationships and recurring revenue streams tied to maintenance contracts and consumables. At the same time, newer entrants and specialist vendors focused on specific applications such as genomics or high-throughput screening introduce targeted innovations that force incumbents to broaden their solution sets or form partnerships. Collaboration between hardware manufacturers and software providers is accelerating, with integration partnerships and validated workflow bundles becoming important mechanisms to lower adoption barriers for large institutional buyers.

In this competitive context, strategic moves such as platform interoperability, open architecture adoption, and investments in local support capabilities are decisive. Firms that can demonstrate measurable improvements in laboratory throughput, reproducibility, and compliance while offering predictable total cost of ownership stand the best chance of winning large accounts across academic, industrial, and clinical markets.

Actionable recommendations for technology strategy, supply chain resilience, and service-led commercialization to accelerate adoption and reduce operational risk

Industry leaders should adopt a multi-pronged strategy that balances near-term resilience with long-term capability building. Begin by prioritizing modular architectures and interoperable software to reduce vendor lock-in and accelerate the pace of deployment. This approach enables laboratories to scale capacity incrementally while preserving flexibility to adopt new technologies and workflows as scientific needs evolve. Concurrently, invest in comprehensive service models that include consulting, installation, proactive maintenance, and training to ensure high uptime and faster time-to-value for customers.

Supply chain resilience should be elevated to a strategic priority. Diversify component sourcing, qualify regional manufacturing partners, and redesign logistics to shorten lead times for critical parts. These actions will mitigate the impact of trade friction and tariff fluctuations while improving service response times. Leaders should also deepen engagement with end users to co-develop validated workflows and performance guarantees that align with specific application demands such as clinical diagnostics or genomics. On the software front, prioritize open APIs, data security, and flexible deployment models to accommodate cloud and on-premises preferences driven by regulatory and data sovereignty concerns.

Finally, invest in workforce transformation programs that combine application training, automation engineering, and data literacy to maximize instrument utilization and drive continuous process improvement. Strategic partnerships and selective investments in emerging technology companies can accelerate innovation without compromising core operational focus. Executed together, these actions will improve commercial resilience, enhance customer retention, and unlock new revenue streams tied to services and software.

Transparent mixed-methods research approach combining practitioner interviews, supply chain mapping, and product architecture analysis to ensure actionable and reproducible insights

This research synthesizes qualitative and quantitative sources to ensure robust, triangulated insights. The methodology combines structured interviews with laboratory directors, procurement leads, automation engineers, and software architects to capture practitioner perspectives on adoption barriers, validation requirements, and service expectations. These primary inputs are complemented by technology scans and product architecture mappings that document current instrument capabilities, robotics classes, and software interoperability patterns.

Supplementary analysis includes supply chain mapping to identify sourcing dependencies and potential bottlenecks, as well as case studies that illustrate successful deployments across clinical diagnostics, drug discovery, genomics, microbiology, and proteomics. Vendor profile assessments emphasize product roadmaps, service portfolios, and software ecosystems, while comparative evaluations focus on deployment complexity, regulatory readiness, and post-deployment support models. Data triangulation techniques are applied to reconcile differing stakeholder viewpoints and to highlight consensus around critical adoption drivers.

Throughout the research process, attention was paid to ensuring relevance across regions by interrogating how regulatory frameworks, procurement practices, and local service capabilities influence adoption. The methodology is designed to be transparent and reproducible, enabling decision-makers to understand the evidence base behind each conclusion and to request tailored extensions or deep-dives focused on specific technologies or geographies.

Concise concluding synthesis emphasizing the integrated capability approach and strategic imperatives for sustained laboratory automation value realization

Laboratory automation is at a strategic inflection point where technology, services, and policy shifts converge to reshape how laboratories operate and scale. The combined effect of modular system adoption, integrated software ecosystems, and service-oriented commercial models points to a future in which value is measured not by instrument sales alone but by demonstrable improvements in throughput, reproducibility, and operational resilience. Tariff-driven supply chain recalibrations underscore the importance of regional manufacturing, diversified sourcing, and stronger vendor-buyer collaboration to maintain continuity of operations.

Across applications-from clinical diagnostics to proteomics-the demand for validated workflows and interoperable data infrastructures will increasingly determine procurement decisions. End users will reward vendors that can reduce adoption friction through pre-validated solution bundles, strong training programs, and predictable service commitments. For vendors, the path to differentiation runs through platform openness, robust after-sales support, and the ability to partner effectively with specialized technology firms to address niche application needs.

In summary, stakeholders who align product development, commercial models, and supply chain strategies with the evolving expectations of laboratories will be better positioned to capture long-term value. Decision-makers should treat automation not as a series of hardware purchases but as an integrated capability that requires concerted investments in software, services, and organizational readiness to deliver sustained benefits.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2024
• 3.5. FPNV Positioning Matrix, 2024
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Laboratory Automation Market, by Type

• 8.1. Modular Automation Solutions
• 8.2. Total Automation Solutions

9. Laboratory Automation Market, by Offering

• 9.1. Laboratory Instruments
  • 9.1.1. Automated Liquid Handling Systems
  • 9.1.2. Automated Microplate Readers
  • 9.1.3. Automated Sampling Systems
  • 9.1.4. Automated Storage & Retrieval Systems
  • 9.1.5. Robotic Arms
    • 9.1.5.1. Cartesian Robot
    • 9.1.5.2. SCARA Robot
• 9.2. Service
  • 9.2.1. Consulting Services
  • 9.2.2. Installation & Maintenance
  • 9.2.3. Training & Support Services
• 9.3. Software
  • 9.3.1. Chromatography Data System (CDS)
  • 9.3.2. Electronic Lab Notebook
  • 9.3.3. Laboratory Information Management System (LIMS)
  • 9.3.4. Scientific Data Management System (SDMS)

10. Laboratory Automation Market, by Deployment Mode

• 10.1. On Premises
• 10.2. Cloud Based
• 10.3. Hybrid

11. Laboratory Automation Market, by Application

• 11.1. Clinical Diagnostics
• 11.2. Drug Discovery
• 11.3. Genomics
• 11.4. Microbiology
• 11.5. Proteomics

12. Laboratory Automation Market, by End User

• 12.1. Academic & Research Institutes
• 12.2. Biotechnology & Pharmaceutical Companies
• 12.3. Environmental Testing Laboratories
• 12.4. Food & Beverage Industry
• 12.5. Hospitals & Diagnostic Laboratories

13. Laboratory Automation Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Laboratory Automation Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Laboratory Automation Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. United States Laboratory Automation Market

17. China Laboratory Automation Market

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2024
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2024
• 18.3. Product Portfolio Analysis, 2024
• 18.4. Benchmarking Analysis, 2024
• 18.5. Abbott Laboratories
• 18.6. Agilent Technologies, Inc.
• 18.7. Beckman Coulter by Danaher Corporation
• 18.8. BECTON, DICKINSON AND COMPANY
• 18.9. F. Hoffmann-La Roche Ltd.
• 18.10. Hamilton Company
• 18.11. Merck & Co., Inc.
• 18.12. QIAGEN N.V.
• 18.13. Siemens AG
• 18.14. Thermo Fisher Scientific Inc.